restor3d, a supplier of patient-specific 3D-printed implants, is merging with Kinos Medical, a total ankle replacement manufacturer.
restor3d has a robust pipeline of products slated for regulatory submission. Recent FDA clearances include osteotomy wedges and cervical interbody fusion implants. The merger with Kinos will accelerate restor3d’s expansion into the U.S. foot and ankle market.
Kinos’ Axiom total ankle is reportedly the first biomechanically accurate implant on the market, offering motion in all three anatomic planes, as is seen in the natural ankle.
The Kinos portfolio mirrors the vision of restor3d, where pre-operative planning, superior implant design and intraoperative guidance is tailored to the individual needs of the patient and surgeon.
“restor3d and Kinos share an uncommon, persistent dedication to science and technology in the pursuit of improving patients’ outcomes and healthcare, and I am very excited to have found peers in arthroplasty whose products reflect this,” said Andy Miller Ph.D., co-founder and CEO of restor3d. “By merging the two companies, we will be able to apply our technologies to provide advanced solutions in new device applications that are outside restor3d’s current scope, first in foot and ankle, and then followed by other areas of medicine. The unique combination of expertise between restor3d and Kinos will lead to products that are truly at the leading edge.”
restor3d, a supplier of patient-specific 3D-printed implants, is merging with Kinos Medical, a total ankle replacement manufacturer.
restor3d has a robust pipeline of products slated for regulatory submission. Recent FDA clearances include osteotomy wedges and cervical interbody fusion implants. The merger with Kinos will accelerate...
restor3d, a supplier of patient-specific 3D-printed implants, is merging with Kinos Medical, a total ankle replacement manufacturer.
restor3d has a robust pipeline of products slated for regulatory submission. Recent FDA clearances include osteotomy wedges and cervical interbody fusion implants. The merger with Kinos will accelerate restor3d’s expansion into the U.S. foot and ankle market.
Kinos’ Axiom total ankle is reportedly the first biomechanically accurate implant on the market, offering motion in all three anatomic planes, as is seen in the natural ankle.
The Kinos portfolio mirrors the vision of restor3d, where pre-operative planning, superior implant design and intraoperative guidance is tailored to the individual needs of the patient and surgeon.
“restor3d and Kinos share an uncommon, persistent dedication to science and technology in the pursuit of improving patients’ outcomes and healthcare, and I am very excited to have found peers in arthroplasty whose products reflect this,” said Andy Miller Ph.D., co-founder and CEO of restor3d. “By merging the two companies, we will be able to apply our technologies to provide advanced solutions in new device applications that are outside restor3d’s current scope, first in foot and ankle, and then followed by other areas of medicine. The unique combination of expertise between restor3d and Kinos will lead to products that are truly at the leading edge.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
